NexScreen
- Company typePrivate
- Founded2008
- HeadquartersBluffton, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What NexScreen does
NexScreen LLC is a Bluffton, South Carolina–based privately held medical device and services company that manufactures and distributes rapid, point-of-care drug screening products for B2B employer buyers. Its core product portfolio spans FDA 510(k) Cleared and CLIA Waived urine drug test cups (results in 5 minutes, up to 13 drug panels and 6 adulterant screens), urine dip cards (results in ~1 minute, up to 12 panels), oral fluid tests (up to 10 panels), the SAFElife Mobile Hair Processor (10-minute results with a 90-day detection window and up to 17 drug panels), and alcohol/nicotine tests, supplemented by American-made N95 respirators and disposable isolation gowns under NIOSH and Berry Amendment certifications.
The company's revenue model is hybrid. It sells physical POCT consumables on a one-time unit-pricing basis with same-day shipping and volume/industry discounts, while layering on the i3ccf Drug Screening Collection System and the NexScreen Integrated Solutions subscription platform — both deliver electronic CCF capture, scheduling, real-time status, MRO expedited adjudication, random program management, and access to "1000s of lab locations nationwide." Professional services — drug & alcohol testing, background screening & credentialing, and clinical testing services (DOT physicals, vaccinations, wellness testing) — extend the platform into recurring HR-screening workflows. Alere Laboratories serves as the confirmation lab partner for non-negative oral fluid samples.
NexScreen targets employers and HR departments across verticals, with DOT-regulated transportation and healthcare as primary segments, and a secondary long tail across construction, education, energy, financial services, government, hospitality, manufacturing, retail, staffing, and technology. GTM is enterprise field sales via phone (800.232.2403 / 888.956.8989) and a direct e-commerce storefront, supported by content marketing and an in-house certification/training resource center.
NexScreen firmographics
Firmographics- Name
- NexScreen
- Legal name
- NexScreen LLC
- Website
- https://nexscreen.com
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
NexScreen industry classification
Industry- Product category
- Drug Screening & Diagnostics Medical Devices
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Medical and Diagnostic Laboratories (62151)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Drug & Alcohol Testing Coordination (BPACALAE)
- akta.pro secondary industry
- Toxicology & Therapeutic Drug Monitoring Laboratories (HLAFAMAF)
Keywords
Where NexScreen is headquartered
LocationHeadquarters
- HQ city
- Bluffton
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
NexScreen business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Drug Screening Products: Sale of rapid drug test products including urine cups, dip cards, oral fluid tests, hair tests, and alcohol/nicotine tests. Also includes controls and verification products. One-time purchase model with volume discounts available for bulk orders.
- NexScreen Integrated Solutions Software: Subscription-based software platform providing employment screening services, contractor screening services, employment health screening, and clinical lab testing management. One login for all screening services with features including random program management, MRO services, and 1000s of lab locations nationwide.
- Background Screening & Credentialing: Comprehensive background check services including criminal records, identity verification, financial/business checks, and credential verifications. Offered as part of integrated solutions platform.
- Clinical Testing Services: DOT physicals, annual checkups, infectious disease testing, wellness testing, vaccinations, and prescriptive services.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Standard product pricing with volume discounts |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
NexScreen product offering
Product offeringCore offering
NexScreen manufactures and sells FDA 510(k) cleared, CLIA waived rapid drug screening products (urine cups, dip cards, oral fluid tests, alcohol/nicotine tests, hair tests) and personal protective equipment (N95 respirators, disposable gowns). It complements these physical products with the i3ccf drug screening collection software platform and the NexScreen Integrated Solutions platform that consolidate employment screening, contractor screening, health screening, background screening, credentialing, and clinical lab testing under a single login.
Product overview
NexScreen is a drug screening products and technology services company offering a portfolio of physical rapid drug testing products combined with integrated software solutions. The core product line includes Rapid Urine Drug Test Cups (FDA 510(k) Cleared, CLIA Waived), Urine Dip Card Drug Tests, Oral Fluid Drug Tests, Alcohol & Nicotine Tests, and SAFElife Mobile Hair Processor tests—all providing rapid on-site screening results. These physical testing products are complemented by the i3ccf Drug Screening Collection System software platform for automating collection management, scheduling, and MRO adjudication. The NexScreen Integrated Solutions platform unifies employment screening, contractor screening, health screening, and clinical lab testing under one login. Additional services include Drug & Alcohol Testing Services, Background Screening & Credentialing Services, and Clinical Testing Services. The company also supplies PPE products including N95 respirators and disposable isolation gowns.
Differentiator
Problem solved
Functional benefit
Brands
- i3ccf: Drug screening collection system software portal that allows ordering and managing drug tests, scheduling, real-time status updates, electronic signature capture, and MRO expedited adjudication process.
Products and services
- Rapid Urine Drug Test Cup CLIA Waived and FDA 510(k) Cleared rapid urine drug screening cup providing lab-comparable results in 5 minutes with 13 drug and 6 adulterant screening panels; features unbreakable, tamper-proof, leak-proof design. Sold to employers, HR departments, and screening programs.
- Urine Dip Card Drug Test Quick and easy urine-based dip card drug test providing results in approximately 1 minute with up to 12 panel test configurations. CLIA Waived and FDA 510(k) Cleared. Sold to employers and screening programs.
- Oral Fluid Drug Tests Saliva-based oral fluid drug test for detecting recent drug use without gender-specific observation requirements, with up to 10 panel test configurations. CLIA Waived and FDA 510(k) Cleared.
- Alcohol & Nicotine Tests Breath alcohol and nicotine screening tests for detecting recent alcohol consumption and tobacco use. Sold to employers and screening programs.
- SAFElife Mobile Hair Processor Mobile hair drug test processor providing 10-minute results with a comprehensive menu of 17 accurate and reliable drug tests (6-MAM, AMP, BAR, BUP, BZO, COC, FTY, K2, KET, MDMA, MAMP, MTD, OPI, OXY, PCP, TRA, THC). Captures long-term drug use history up to 90 days. Customizable panel options with maximum 12-panel configuration for forensic use.
- Controls Quality control products for verifying the accuracy and reliability of NexScreen drug test results.
- N95 Respirators American-made N95 respirators including foldable and molded models. Foldable model meets NIOSH TEB-APR-STP-0007 standards with 99% BFE (ASTM F2101) and is Berry Amendment compliant; molded model meets CFR 84.172 with Small and Regular sizes.
- Disposable Isolation Gowns American-made SMS spunbond non-woven and polyethylene disposable gowns. SMS gowns are Level 3 AAMI rated; PE gowns are FDA registered (3016784111) with waterproof and anti-static properties.
- i3ccf Drug Screening Collection System Fully customizable all-in-one software portal for automating drug screening collection processes. Enables scheduling rapid drug tests from any device, real-time status updates, electronic signature capture replacing paper CCFs, and MRO expedited adjudication. Subscription-based platform for employers and screening programs.
- NexScreen Integrated Solutions Comprehensive screening platform providing one login for employment screening services, contractor screening services, employment health screening, and clinical lab testing. Includes drug & alcohol testing, background screening & credentialing, and clinical testing services, with random program management, MRO services, and access to thousands of lab locations nationwide.
- Drug & Alcohol Testing Services Comprehensive drug and alcohol testing services including DOT and Non-DOT lab-based testing (urine, hair, oral fluids), breath alcohol tests, random program management, Medical Review Officer (MRO) services, and instant device testing with multiple panel configurations.
- Background Screening & Credentialing Services Full-service background check platform offering criminal background checks, identity & biometrics verification, financial & business checks, monitoring services, onboarding support (Form I-9 & E-Verify), and credential verifications. Serves construction, healthcare, government, education, energy, financial services, hospitality, manufacturing, retail, staffing, technology, and transportation.
- Clinical Testing Services Clinical health testing services including DOT physicals, annual checkups, infectious disease testing, wellness testing, vaccinations, and prescriptive services. Over 1,000 clinical tests available nationwide.
Quantifiable outcome
- 5-minute rapid results for urine drug tests vs. days for lab-based testing
- +3 more outcomes
Companies that use NexScreen
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles4 records
NexScreen technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
NexScreen partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Alere LaboratoriessupportingAlere Laboratories serves as the confirmation lab for TCube oral fluid device non-negative samples. For the TCube device, any non-negative results need to be collected with an Intercept Device and sent to Alere Laboratories for confirmation testing.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
NexScreen competitors and assessment
Company assessmentBroad incumbents
- Abbott (Alere Toxicology): Abbott's rapid diagnostics arm (built around the Alere acquisition, which is also NexScreen's confirmation lab partner) sells workplace drug-screening devices and lab services. It is both a competitor and a back-end lab partner to NexScreen's oral fluid workflow.
- HireRight Holdings: HireRight is a major global background check and workforce screening vendor offering integrated drug testing and occupational health services. It competes directly with NexScreen's bundled screening platform for enterprise HR buyers.
- Laboratory Corporation of America (Labcorp): Labcorp runs one of the largest workplace drug testing and clinical laboratory networks in the US, including DOT-compliant programs. It competes with NexScreen for national employer accounts and offers bundled occupational health services.
- Quest Diagnostics: Quest Diagnostics is the largest US clinical laboratory network and operates a major employer solutions business for drug screening, DOT testing, and background screening. It competes with NexScreen at the enterprise-employer end of the market and is a likely reference-lab partner.
- First Advantage: First Advantage is a leading background screening and employer solutions provider that also offers drug and occupational health screening. It is comparable to NexScreen's Integrated Solutions bundle of background, credentialing, and clinical testing services.
Direct peers
- Psychemedics Corporation: Psychemedics is the leading dedicated hair drug-testing laboratory and product provider. It directly competes with NexScreen's SAFElife Mobile Hair Processor offering for employers seeking longer-detection-window drug screening.
- Omega Laboratories: Omega Laboratories is a specialized toxicology and hair drug-testing laboratory serving employers and legal clients. It competes with NexScreen for employer testing spend, particularly in specialty panels and forensic use cases.
- Confirm BioSciences: Confirm BioSciences sells rapid urine drug test cups, dip cards, oral fluid devices, and multi-panel screening products to employers and resellers. It is a head-to-head competitor in the same product categories NexScreen sells through its e-commerce channel.
Emerging players
- Drägerwerk: Dräger produces drug and alcohol screening instruments (e.g., Alcotest and DrugTest) used by employers and law enforcement. It overlaps with NexScreen on device-based rapid screening for alcohol and drugs in workplace settings.
- Bio-Rad Laboratories: Bio-Rad manufactures a portfolio of in-vitro diagnostic products including quality controls and immunoassay reagents used in toxicology and clinical laboratories. It overlaps with NexScreen on the IVD manufacturing and QC controls side of the business.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
NexScreen social profiles
Digital presenceNexScreen compliance and trust
Trust signalCompliance4 records
NexScreen financial estimates
Financial estimateRevenue estimate
Valuation estimate
NexScreen leadership team
Management profileNumber of profiles
NexScreen funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
NexScreen M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about NexScreen
What does NexScreen do?
NexScreen manufactures and sells FDA 510(k) cleared, CLIA waived rapid drug screening products (urine cups, dip cards, oral fluid tests, alcohol/nicotine tests, hair tests) and personal protective equipment (N95 respirators, disposable gowns). It complements these physical products with the i3ccf drug screening collection software platform and the NexScreen Integrated Solutions platform that consolidate employment screening, contractor screening, health screening, background screening, credentialing, and clinical lab testing under a single login.
Is NexScreen a public or private company?
NexScreen is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was NexScreen founded?
NexScreen was founded in 2008. It employs 1 to 10 people.
Where is NexScreen based?
NexScreen is headquartered in Bluffton, United States, in the North America region.
How does NexScreen make money?
Four revenue lines are on record. Drug Screening Products are the primary driver. The others are nexScreen Integrated Solutions Software, background Screening & Credentialing and clinical Testing Services.
Who are NexScreen's main competitors?
Broad incumbents on record are Abbott (Alere Toxicology), HireRight Holdings, Laboratory Corporation of America (Labcorp), Quest Diagnostics and First Advantage. Direct peers are Psychemedics Corporation, Omega Laboratories and Confirm BioSciences. Emerging players are Drägerwerk and Bio-Rad Laboratories.
Does NexScreen have an API?
No public API is recorded for NexScreen.
What industry is NexScreen in?
NexScreen's product category is Drug Screening & Diagnostics Medical Devices. Its primary akta.pro industry code is BPACALAE, Drug & Alcohol Testing Coordination, with a secondary code of HLAFAMAF, Toxicology & Therapeutic Drug Monitoring Laboratories. Its NAICS code is 325413 and its SIC code is 2835.